<?xml version="1.0" encoding="UTF-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xml:lang="en">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>Sarcopenia: revised European consensus on definition and diagnosis</title>
        <author>Alfonso J. Cruz‐Jentoft</author>
        <author>Gülistan Bahat</author>
        <author>Jürgen M. Bauer</author>
        <author>Yves Boirie‌</author>
        <author>Olivier Bruyère</author>
        <author>Tommy Cederholm</author>
        <author>Cyrus Cooper</author>
        <author>Francesco Landi</author>
        <author>Yves Rolland</author>
        <author>Avan Aihie Sayer</author>
        <author>S. Schneider</author>
        <author>Cornel Sieber</author>
        <author>Eva Topinková</author>
        <author>M. Vandewoude</author>
        <author>Marjolein Visser</author>
        <author>Mauro Zamboni</author>
        <author>Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2</author>
        <author>Ivan Bautmans</author>
        <author>Jean‐Pierre Baeyens</author>
        <author>Matteo Cesari</author>
        <author>Antonio Cherubini</author>
        <author>John А. Kanis</author>
        <author>Marcello Maggio</author>
        <author>Finbarr C. Martin</author>
        <author>Jean‐Pierre Michel</author>
        <author>Kaisu Pitkälä</author>
        <author>Jean‐Yves Reginster</author>
        <author>René Rizzoli</author>
        <author>Dolores Sánchez‐Rodríguez</author>
        <author>Jos M. G. A. Schols</author>
      </titleStmt>
      <publicationStmt>
        <p>Tag layer of the DHSS Meta-Tagging Project. The article text is reproduced from the
           staged copy named in sourceDesc and is not altered; the tags are held separately in
           standOff so that overlapping and nested spans are preserved.</p>
      </publicationStmt>
      <sourceDesc>
        <bibl>
          <title>Sarcopenia: revised European consensus on definition and diagnosis</title>
          <date>2018</date>
          <publisher>Age and Ageing</publisher>
          <idno type="DOI">10.1093/ageing/afy169</idno>
          
          <idno type="record">cruz-jentoft2018-sarcopenia-revised-european-consen</idno>
          <note type="staged-file">cruz-jentoft2018-sarcopenia-revised-european-consen.txt, the project's staged copy</note>
          <note type="text-sha1">d0c3b7c0800e129c3bb2718d13d5e99fa3e36866</note>
          <note type="rights">cc-by-nc</note>
        </bibl>
      </sourceDesc>
    </fileDesc>
    <profileDesc>
      <textClass><keywords><term>medicine</term></keywords></textClass>
      <particDesc>
        <person xml:id="paper"><p>the paper's own words</p></person>
        <person xml:id="tagger"><p>the tag layer; a sentence written by the tagger about the
          paper, always anchored to a quotation but not itself a quotation</p></person>
      </particDesc>
    </profileDesc>
    <revisionDesc>
      <change when="2026-10-06"
              who="build_paper_edition.py">0 spans located by searching the stored text for the quote's exact words, allowing any whitespace between them</change>
    </revisionDesc>
  </teiHeader>
  <standOff>
    <spanGrp type="tags">
      <span xml:id="t0" type="object_of_study" ana="#object_of_study" resp="#paper">
        <label>the definition of sarcopenia itself - what the term should pick out, which variables identify it, and at what thresholds</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t1" type="research_question" ana="#research_question" resp="#paper">
        <label>whether a decade of evidence justified changing the 2010 definition, and if so which parameter should be primary</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t2" type="contribution" ana="#contribution" resp="#paper">
        <label>a revised operational definition in which muscle strength replaces muscle mass as the primary parameter, plus the cut-off points the 2010 consensus declined to give</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t3" type="claim_type" ana="#claim_type" resp="#paper">
        <label>method</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t4" type="phenomenon" ana="#phenomenon" resp="#paper">
        <label>sarcopenia - a progressive generalised skeletal muscle disorder, now classed as a muscle disease, carrying raised risk of falls, fractures, disability and death</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t5" type="method" ana="#method" resp="#paper">
        <label>expert-consensus</label>
        <term>expert-consensus</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t6" type="mechanisms" ana="#mechanisms[0]" resp="#tagger" cert="0.95">
        <label>why the primary parameter changed: strength predicts adverse outcomes better than mass does, so putting it first is expected to speed up identification in practice - a change justified by predictive validity, not by new biology</label>
        <term>strength before mass</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t7" type="mechanisms" ana="#mechanisms[1]" resp="#tagger" cert="0.95">
        <label>why quantity and quality are NOT primary despite being part of the definition - they are technically difficult to measure accurately, so the constraint on the definition is instrumentation rather than concept</label>
        <term>technological limit</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t8" type="mechanisms" ana="#mechanisms[2]" resp="#tagger" cert="0.95">
        <label>BIA does not measure muscle mass; it estimates it from whole-body conductivity using an equation calibrated against DXA in a specific population - so a BIA reading inherits both DXA&#x27;s error and the reference population&#x27;s demography</label>
        <term>measurement chained on measurement</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t9" type="mechanisms" ana="#mechanisms[3]" resp="#tagger" cert="0.95">
        <label>the mechanism by which an incomplete definition damages a field: with no cut-off points advised, studies chose their own, and the resulting disputes are said to have hampered research and development</label>
        <term>threshold silence</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t10" type="mechanisms" ana="#mechanisms[4]" resp="#tagger" cert="0.95">
        <label>A REGIONAL FORK FIXED THE PARENT STANDARD AND THE PARENT ADOPTED THE FIX BACK: `Quotation withheld More recently, the Asian Working Group on Sarcopenia developed an EWGSOP-based consensus that specified cut-off points ... The cut-off points in the Asian consensus proved to be very useful ... Thus, EWGSOP2 has opted to provide recommendations for cut-off points.` A derived standard added what its parent left out, the addition worked, and the parent then took it back in - a fork and a merge in the history of one definition, both steps stated in one paragraph.</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t11" type="mechanisms" ana="#mechanisms[5]" resp="#tagger" cert="0.9">
        <label>AND THE THRESHOLDS ARE SCOPED TO A POPULATION IN THE SAME BREATH AS THEY ARE PUBLISHED: `The current EWGSOP recommendations focus on European populations and use of normative references (healthy young ... ) ... we recommend use of regional normative populations when available.` The numbers in Table 3 are offered as universal diagnostic criteria and qualified as regional in the surrounding prose - which is exactly the condition that produced the Asian fork.</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t12" type="limitations" ana="#limitations[0]" resp="#tagger" cert="0.95">
        <label>the authors say their own cut-off points are ARBITRARY at this time, and that validated ones await normative data and predictive value against hard end-points</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t13" type="limitations" ana="#limitations[1]" resp="#tagger" cert="0.95">
        <label>the cut-offs are set for European populations against healthy-young-adult references at −2 SD, with −2.5 SD offered for a more conservative diagnosis - so the boundary is a choice on a continuum, not a natural break</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t14" type="limitations" ana="#limitations[2]" resp="#tagger" cert="0.95">
        <label>round figures were preferred to accurate ones, deliberately, for ease of use</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t15" type="limitations" ana="#limitations[3]" resp="#tagger" cert="0.95">
        <label>gait speed and strength depend on stature, so regional normative populations are needed and are not always available</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t16" type="limitations" ana="#limitations[4]" resp="#tagger" cert="0.95">
        <label>different DXA instrument brands do not give consistent results, and DXA is the instrument advised for confirming the diagnosis in clinical practice</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t17" type="limitations" ana="#limitations[5]" resp="#tagger" cert="0.95">
        <label>MRI and CT are the gold standards for muscle quantity and cut-off points for low muscle mass are not yet well defined for them - the best instrument has no threshold</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t18" type="limitations" ana="#limitations[6]" resp="#tagger" cert="0.95">
        <label>BIA prediction models belong to the populations they were derived in, and the recommended equation is based on older Europeans</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t19" type="limitations" ana="#limitations[7]" resp="#tagger" cert="0.95">
        <label>no recommendation is made on whether to adjust muscle mass for body size, and the authors record that the choice between height-squared, weight and BMI is under debate</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t20" type="limitations" ana="#limitations[8]" resp="#tagger" cert="0.95">
        <label>the recommended screening questionnaire has low-to-moderate sensitivity - it will mostly detect severe cases, so screening with it misses the mild ones the paper wants found early</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t21" type="limitations" ana="#limitations[9]" resp="#tagger" cert="0.95">
        <label>sarcopenic obesity is declared outside the scope of the article while being acknowledged as a distinct condition with its own definitional work ongoing</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t22" type="limitations" ana="#limitations[10]" resp="#tagger" cert="0.95">
        <label>the research-gap list is the authors&#x27; own: causes and life-course intervention points, risk identification, validated cut-offs, gender- and region-specific thresholds, muscle-quality indicators, the kinetics of loss, and which outcomes measure treatment response</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t23" type="controls" ana="#controls[0]" resp="#tagger" cert="0.95">
        <label>two structured face-to-face meetings with literature searches between them, a circulated draft, email review by both groups, and a final poll of all members for agreement</label>
        <note>eliminates: the recommendations being the view of whoever wrote the draft - every member was polled on the final content, and the disagreement had somewhere to go before publication · outcome: held</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t24" type="controls" ana="#controls[1]" resp="#tagger" cert="0.9">
        <label>including the original EWGSOP members alongside newly recruited European researchers in a 16-member writing group and a 13-member extended group</label>
        <note>eliminates: a revision made by a different set of people from the original, which would leave it open whether the definition changed because the evidence changed or because the committee did · outcome: held</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t25" type="controls" ana="#controls[2]" resp="#tagger" cert="0.9">
        <label>review and endorsement by five independent scientific societies after completion</label>
        <note>eliminates: a single society&#x27;s consensus being taken for the field&#x27;s - the definition carries geriatrics, nutrition, osteoporosis and gerontology bodies behind it · outcome: held</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t26" type="controls" ana="#controls[3]" resp="#tagger" cert="0.95">
        <label>setting cut-off points against normative references of healthy young adults at −2 standard deviations, with −2.5 SD available where a conservative diagnosis is wanted</label>
        <note>eliminates: each study picking its own threshold, which is the specific failure the authors attribute to the 2010 consensus having advised none · outcome: partial</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t27" type="controls" ana="#controls[4]" resp="#tagger" cert="0.9">
        <label>taking the Asian Working Group&#x27;s EWGSOP-based consensus, which did specify cut-off points, as evidence that specifying them helps</label>
        <note>eliminates: the decision to give thresholds being untested - another group had already done it and the result was reported as very useful for implementation · outcome: held</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t28" type="controls" ana="#controls[5]" resp="#tagger" cert="0.95">
        <label>separating sarcopenia from frailty, sarcopenic obesity and malnutrition explicitly, each in its own subsection</label>
        <note>eliminates: the new definition absorbing its neighbours - frailty overlaps on grip strength and gait speed and is still held to be a different KIND of thing, a geriatric syndrome rather than a disease · outcome: held</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t29" type="controls" ana="#controls[6]" resp="#tagger" cert="0.95">
        <label>recording that other experts argue CT psoas measurement is not representative of overall sarcopenia, and that further studies are needed to verify or reject it</label>
        <note>eliminates: a method being adopted into the consensus on the strength of its convenience - the objection is printed rather than resolved · outcome: held</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t30" type="concepts" ana="#concepts[0]" resp="#paper" cert="0.95">
        <label>sarcopenia</label>
        <term>sarcopenia</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t31" type="concepts" ana="#concepts[1]" resp="#paper" cert="0.95">
        <label>muscle strength</label>
        <term>muscle strength</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t32" type="concepts" ana="#concepts[2]" resp="#paper" cert="0.95">
        <label>muscle mass</label>
        <term>muscle mass</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t33" type="concepts" ana="#concepts[3]" resp="#paper" cert="0.95">
        <label>muscle quality</label>
        <term>muscle quality</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t34" type="concepts" ana="#concepts[4]" resp="#paper" cert="0.95">
        <label>physical performance</label>
        <term>physical performance</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t35" type="concepts" ana="#concepts[5]" resp="#paper" cert="0.95">
        <label>grip strength</label>
        <term>grip strength</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t36" type="concepts" ana="#concepts[6]" resp="#paper" cert="0.95">
        <label>chair stand test</label>
        <term>chair stand test</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t37" type="concepts" ana="#concepts[7]" resp="#paper" cert="0.95">
        <label>gait speed</label>
        <term>gait speed</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t38" type="concepts" ana="#concepts[8]" resp="#paper" cert="0.95">
        <label>DXA</label>
        <term>DXA</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t39" type="concepts" ana="#concepts[9]" resp="#paper" cert="0.95">
        <label>BIA</label>
        <term>BIA</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t40" type="concepts" ana="#concepts[10]" resp="#paper" cert="0.95">
        <label>SARC-F</label>
        <term>SARC-F</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t41" type="concepts" ana="#concepts[11]" resp="#paper" cert="0.95">
        <label>anthropometry</label>
        <term>anthropometry</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t42" type="concepts" ana="#concepts[12]" resp="#paper" cert="0.95">
        <label>cut-off points</label>
        <term>cut-off points</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t43" type="concepts" ana="#concepts[13]" resp="#paper" cert="0.95">
        <label>frailty</label>
        <term>frailty</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t44" type="concepts" ana="#concepts[14]" resp="#paper" cert="0.95">
        <label>malnutrition</label>
        <term>malnutrition</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t45" type="concepts" ana="#concepts[15]" resp="#paper" cert="0.95">
        <label>ageing</label>
        <term>ageing</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t46" type="concepts" ana="#concepts[16]" resp="#paper" cert="0.95">
        <label>muscle disease</label>
        <term>muscle disease</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t47" type="concepts" ana="#concepts[17]" resp="#paper" cert="0.95">
        <label>geriatric syndrome</label>
        <term>geriatric syndrome</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t48" type="concepts" ana="#concepts[18]" resp="#paper" cert="0.95">
        <label>Asian Working Group on Sarcopenia</label>
        <term>Asian Working Group on Sarcopenia</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t49" type="unhoused_relations" ana="#unhoused_relations[0]" resp="#tagger">
        <label>cut-off points → sarcopenia</label>
        <note>A DEFINITION DAMAGED THE FIELD BY WHAT IT LEFT OUT. The 2010 consensus advised no cut-off points, and the paper says the resulting disputes HAMPERED RESEARCH AND DEVELOPMENT through lack of study consistency. The relation is between an ABSENCE in a definition and harm to a research literature, and there is no edge type for it - &#x27;causes&#x27; would need the &#x27;from&#x27; endpoint to be the missing thresholds, which are not a thing that existed</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t50" type="unhoused_relations" ana="#unhoused_relations[1]" resp="#tagger">
        <label>SARC-F → sarcopenia</label>
        <note>A SCREEN THAT MISSES WHAT THE PAPER WANTS FOUND. SARC-F has low-to-moderate sensitivity and very high specificity, so it &#x27;will mostly detect severe cases&#x27; - and the stated purpose of the whole revision is EARLY detection. &#x27;operationalised-as&#x27; asserts the instrument measures the construct; the true relation is that it measures one end of it, and the schema has no way to say which end</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t51" type="senses" ana="#senses[0]" resp="#tagger" cert="0.95">
        <label>sarcopenia - THREE DATED SENSES, ALL THREE NAMED IN THIS ONE SENTENCE. Before 2010 the term meant low muscle MASS alone. EWGSOP 2010 added muscle FUNCTION, which the authors call `a major change at that time`. EWGSOP2 2018 puts muscle STRENGTH at the forefront because strength predicts adverse outcomes better than mass does. A study citing `sarcopenia` without a date is citing one of three different populations</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t52" type="senses" ana="#senses[1]" resp="#tagger" cert="0.95">
        <label>physical performance - ONE VARIABLE, THREE ROLES, IN ONE SENTENCE. It was part of the core definition; other groups used it as an OUTCOME MEASURE, which makes it a dependent variable rather than a criterion; EWGSOP2 now uses it to grade SEVERITY. The same measurement is a definiens, an outcome and a severity scale depending on whose paper you are reading</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t53" type="senses" ana="#senses[2]" resp="#tagger" cert="0.95">
        <label>probable sarcopenia versus confirmed sarcopenia - A TWO-STAGE DIAGNOSIS AND THE STAGES REQUIRE DIFFERENT EQUIPMENT. Low strength alone makes it PROBABLE, which a dynamometer can establish anywhere; CONFIRMED needs muscle quantity or quality, which needs DXA, BIA, CT or MRI. So a prevalence figure depends on what machines the study had, and the design makes that explicit rather than hiding it</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t54" type="senses" ana="#senses[3]" resp="#tagger" cert="0.95">
        <label>muscle quality - A RELATIVELY NEW TERM WITH FOUR INCOMPATIBLE OPERATIONALISATIONS LISTED IN ONE PARAGRAPH: fat infiltration and attenuation on MRI or CT, the ratio of strength to appendicular skeletal muscle mass, the ratio to muscle volume, and BIA-derived phase angle. The paper says outright there is no universal consensus on assessment. Two papers reporting `muscle quality` may share no measurement at all</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t55" type="senses" ana="#senses[4]" resp="#tagger" cert="0.95">
        <label>cut-off point, in EWGSOP2 - A ROUND NUMBER CHOSEN FOR USABILITY, and the paper says so: `we opted to use round figures, with the confidence that the minor reduction in accuracy will be overcome by ease of use`. Grip strength &lt;27 kg and &lt;16 kg are not measured boundaries, they are −2 SD against a young reference, rounded</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t56" type="senses" ana="#senses[5]" resp="#tagger" cert="0.95">
        <label>acute versus chronic sarcopenia - A NEW DISTINCTION MADE ON DURATION ALONE, at six months, and made in order to change BEHAVIOUR rather than to describe biology: the point is to force periodic reassessment so the rate of change is visible. A category defined by a clock</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t57" type="claim_relations" ana="#claim_relations[0]" resp="#tagger" cert="0.95">
        <label>extends → EWGSOP&#x27;s own 2010 definition, which added muscle function to definitions based only on low muscle mass</label>
        <note>note: the relation is to the AUTHORS&#x27; OWN earlier consensus, and the paper is explicit that the 2010 version was itself a major change to what came before it - so this is the third position in a documented sequence, not a first revision</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t58" type="claim_relations" ana="#claim_relations[1]" resp="#tagger" cert="0.9">
        <label>qualifies → the pre-2010 definitions of sarcopenia based only on detection of low muscle mass</label>
        <note>note: AUDIT CHANGED THIS FROM &#x27;contradicts&#x27;. Mass is not rejected here and the paper never says the old criterion was wrong - mass is DEMOTED, from the primary parameter to the confirming one, on evidence that strength predicts adverse outcomes better. It still appears in the 2018 definition as criterion 2. A demotion is a qualification</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t59" type="claim_relations" ana="#claim_relations[2]" resp="#tagger" cert="0.95">
        <label>builds-on → the Asian Working Group on Sarcopenia&#x27;s EWGSOP-based consensus, which specified cut-off points and was found useful for implementation</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t60" type="claim_relations" ana="#claim_relations[3]" resp="#tagger" cert="0.95">
        <label>distinguishes-from → Fried and co-workers&#x27; physical phenotype of frailty, which overlaps sarcopenia on grip strength, gait speed and weight loss</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t61" type="claim_relations" ana="#claim_relations[4]" resp="#tagger" cert="0.9">
        <label>distinguishes-from → the proposal that low muscle mass become part of the definition of malnutrition</label>
        <note>note: the same measurement entering a SECOND definition, and the paper marks the difference by what is absent - low fat mass is usually present in malnutrition and not necessarily in sarcopenia</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t62" type="claim_relations" ana="#claim_relations[5]" resp="#tagger" cert="0.95">
        <label>builds-on → expert groups worldwide who have published complementary definitions of sarcopenia in the intervening decade</label>
        <note>note: re-cut in the audit onto the sentence that actually says it. And the word is the paper&#x27;s own: COMPLEMENTARY definitions, not competing ones - so the term had at least three more senses in circulation while this revision was being written</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t63" type="claim_relations" ana="#claim_relations[6]" resp="#tagger" cert="0.95">
        <label>builds-on → the Asian Working Group on Sarcopenia&#x27;s EWGSOP-based consensus, which specified cut-off points the original EWGSOP paper omitted</label>
        <note>note: The direction is worth recording: the ASIAN group derived from EWGSOP, and EWGSOP2 then cites the derived work&#x27;s success as its reason to change. Influence running from the fork back to the parent.</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t64" type="concept_edges" ana="#concept_edges[0]" resp="#tagger">
        <label>sarcopenia —is-a→ muscle disease</label>
        <term>sarcopenia</term>
        <term>muscle disease</term>
        <note>strength of the relation: 0.95 · note: the reclassification is itself one of the paper&#x27;s changes - and it is what the ICD-10 code follows from, so the ontological move has a billing consequence</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t65" type="concept_edges" ana="#concept_edges[1]" resp="#tagger">
        <label>frailty —is-a→ geriatric syndrome</label>
        <term>frailty</term>
        <term>geriatric syndrome</term>
        <note>strength of the relation: 0.95</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t66" type="concept_edges" ana="#concept_edges[2]" resp="#tagger">
        <label>sarcopenia —distinct-from→ frailty</label>
        <term>sarcopenia</term>
        <term>frailty</term>
        <note>strength of the relation: 0.95 · note: and the distinction is made at the level of KIND, not of degree: a disease against a syndrome, even though both are diagnosed partly by grip strength and gait speed</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t67" type="concept_edges" ana="#concept_edges[3]" resp="#tagger">
        <label>sarcopenia —distinct-from→ malnutrition</label>
        <term>sarcopenia</term>
        <term>malnutrition</term>
        <note>strength of the relation: 0.85 · note: the discriminator the paper offers is an ABSENCE - low fat mass is usually present in malnutrition and not necessarily in sarcopenia. The shared feature, low muscle mass, is being proposed as part of the malnutrition definition too</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t68" type="concept_edges" ana="#concept_edges[4]" resp="#tagger">
        <label>muscle strength —operationalised-as→ grip strength</label>
        <term>muscle strength</term>
        <term>grip strength</term>
        <note>strength of the relation: 0.95 · note: and the paper is careful about the warrant: grip correlates only MODERATELY with strength elsewhere in the body and is called a surrogate
Audit 2026-09-28: DOUBTFUL - read against its full span and kept, but endpoint by anaphora: the section is headed &#x27;Muscle strength&#x27; (immediately before the span).</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t69" type="concept_edges" ana="#concept_edges[5]" resp="#tagger">
        <label>muscle strength —operationalised-as→ chair stand test</label>
        <term>muscle strength</term>
        <term>chair stand test</term>
        <note>strength of the relation: 0.8 · note: the paper&#x27;s own hedge is in the tag: the test needs endurance as well as strength, so it is &#x27;a qualified but convenient measure&#x27;
Audit 2026-09-28: DOUBTFUL - read against its full span and kept, but the span writes &#x27;a ... measure of strength&#x27;, not &#x27;muscle strength&#x27;.</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t70" type="concept_edges" ana="#concept_edges[7]" resp="#tagger">
        <label>muscle mass —operationalised-as→ DXA</label>
        <term>muscle mass</term>
        <term>DXA</term>
        <note>strength of the relation: 0.85 · note: weight below 1.0 because the same quote that establishes the operationalisation says different DXA brands disagree</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t71" type="concept_edges" ana="#concept_edges[8]" resp="#tagger">
        <label>muscle mass —operationalised-as→ BIA</label>
        <term>muscle mass</term>
        <term>BIA</term>
        <note>strength of the relation: 0.7 · note: the weakest of the four and deliberately so: BIA does not measure mass, it estimates it from conductivity through an equation calibrated against DXA. The chain is conductivity -&gt; equation -&gt; DXA -&gt; mass</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t72" type="concept_edges" ana="#concept_edges[9]" resp="#tagger">
        <label>ageing —causes→ sarcopenia</label>
        <term>ageing</term>
        <term>sarcopenia</term>
        <note>direction on the measure: increases · strength of the relation: 0.85 · note: and the edge is exactly as strong as the residual category allows - &#x27;primary&#x27; means no OTHER cause was found, which is a diagnosis of exclusion rather than a demonstrated mechanism
Audit 2026-09-28: DOUBTFUL - read against its full span and kept, but sarcopenia is DEFINED as primary when ageing is the only evident cause; causes[increases] is loose.</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t73" type="concept_edges" ana="#concept_edges[10]" resp="#tagger">
        <label>sarcopenia —causes→ frailty</label>
        <term>sarcopenia</term>
        <term>frailty</term>
        <note>direction on the measure: increases · strength of the relation: 0.8</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t74" type="content_tags" ana="#content_tags.findings[0]" resp="#tagger" cert="0.95">
        <label>muscle strength replaces muscle mass as the primary parameter, because strength predicts adverse outcomes better</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t75" type="content_tags" ana="#content_tags.findings[1]" resp="#tagger" cert="0.95">
        <label>the diagnosis becomes two-stage: low strength = PROBABLE sarcopenia; low muscle quantity or quality CONFIRMS it; adding low physical performance makes it SEVERE</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t76" type="content_tags" ana="#content_tags.findings[2]" resp="#tagger" cert="0.95">
        <label>physical performance is demoted from definitional criterion to severity grader</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t77" type="content_tags" ana="#content_tags.findings[3]" resp="#tagger" cert="0.95">
        <label>sarcopenia is reclassified as a muscle disease and now carries an ICD-10-MC diagnosis code billable in some countries</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t78" type="content_tags" ana="#content_tags.findings[4]" resp="#tagger" cert="0.95">
        <label>two new subcategories on duration alone: acute under six months, chronic at six months or more</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t79" type="content_tags" ana="#content_tags.findings[5]" resp="#tagger" cert="0.95">
        <label>sarcopenia is no longer treated as beginning in old age - development is now recognised to begin earlier in life with causes beyond ageing</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t80" type="content_tags" ana="#content_tags.findings[6]" resp="#tagger" cert="0.95">
        <label>the 2010 consensus advised no cut-off points and the resulting disputes are said to have hampered research and development in the field</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t81" type="content_tags" ana="#content_tags.definitions[0]" resp="#tagger" cert="0.95">
        <label>sarcopenia = a progressive and generalised skeletal muscle disorder associated with increased likelihood of falls, fractures, physical disability and mortality</label>
        <term>sarcopenia</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t82" type="content_tags" ana="#content_tags.definitions[1]" resp="#tagger" cert="0.95">
        <label>the 2018 operational definition in three criteria: low muscle strength, low muscle quantity or quality, low physical performance</label>
        <term>sarcopenia</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t83" type="content_tags" ana="#content_tags.definitions[2]" resp="#tagger" cert="0.95">
        <label>primary sarcopenia = no cause other than ageing is evident; secondary = other causal factors are present</label>
        <term>primary sarcopenia</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t84" type="content_tags" ana="#content_tags.definitions[3]" resp="#tagger" cert="0.95">
        <label>muscle quality = micro- and macroscopic changes in muscle architecture and composition, AND muscle function delivered per unit of muscle mass - two senses in one sentence</label>
        <term>muscle quality</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t85" type="content_tags" ana="#content_tags.definitions[4]" resp="#tagger" cert="0.95">
        <label>physical performance = objectively measured whole-body function related to locomotion, involving nervous function and balance as well as muscle</label>
        <term>physical performance</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t86" type="content_tags" ana="#content_tags.definitions[5]" resp="#tagger" cert="0.95">
        <label>the recommended pathway, Find cases - Assess - Confirm - Severity</label>
        <term>Find-Assess-Confirm-Severity</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t87" type="content_tags" ana="#content_tags.statistics[0]" resp="#tagger" cert="0.95">
        <label>cut-off points are set at −2 standard deviations below a healthy-young-adult reference mean, with −2.5 SD offered for a more conservative diagnosis</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t88" type="content_tags" ana="#content_tags.statistics[1]" resp="#tagger" cert="0.95">
        <label>and then rounded, deliberately, trading accuracy for ease of use</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t89" type="content_tags" ana="#content_tags.statistics[2]" resp="#tagger" cert="0.95">
        <label>the authors state that some of their own cut-off points are arbitrary at this time</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t90" type="content_tags" ana="#content_tags.statistics[3]" resp="#tagger" cert="0.95">
        <label>SARC-F: low-to-moderate sensitivity, very high specificity - it will mostly detect severe cases</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t91" type="content_tags" ana="#content_tags.statistics[4]" resp="#tagger" cert="0.95">
        <label>hospitalised older adults with sarcopenia on admission were more than 5-fold more likely to incur higher hospital costs; Czech community data put direct healthcare costs more than 2-fold higher</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t92" type="content_tags" ana="#content_tags.variables[0]" resp="#tagger" cert="0.95">
        <label>muscle strength - the primary parameter, measured by grip strength or chair stand</label>
        <term>muscle strength</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t93" type="content_tags" ana="#content_tags.variables[1]" resp="#tagger" cert="0.95">
        <label>muscle quantity and quality - the confirming parameter, measured by DXA, BIA, CT or MRI, and held back from primacy by technological limits rather than by concept</label>
        <term>muscle quantity/quality</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t94" type="content_tags" ana="#content_tags.variables[2]" resp="#tagger" cert="0.95">
        <label>physical performance - the severity grader, measured by gait speed, SPPB, TUG or the 400-m walk</label>
        <term>physical performance</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
    </spanGrp>
  </standOff>
  <text>
    <body>
      <p><note type="rights">The full text of this article is not redistributable, so it is
      not included here. The evidence sentences are withheld with it; the tag layer and its
      grounding status remain. The article itself is at https://doi.org/10.1093/ageing/afy169.</note></p>
    </body>
  </text>
</TEI>
